Anti-Inflammatory Effects of miR-369-3p via PDE4B in Intestinal Inflammatory Response
International Journal of Molecular Sciences · 02.08.2024 · 25 (15) · 8463
DOI: 10.3390/ijms25158463 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.08.2024. Verfasst von Viviana Scalavino und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, 70013 Castellana Grotte, Italy. Hauptthemen laut MEDLINE: Cyclic Nucleotide Phosphodiesterases, Type 4, Inflammatory Bowel Diseases, MicroRNAs. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministry of Health.
Abstract (Originalsprache)
Cyclic nucleotide phosphodiesterases (PDEs) consist of a family of enzymes expressed in several types of cells, including inflammatory cells, that play a pivotal role in inflammation. Several studies have demonstrated that the inhibition of PDE4 results in a reduced inflammatory response via PKA and CREB signaling. Hence, PDE4 suppression improves the inflammatory feedback typical of several diseases, such as inflammatory bowel disease (IBD). In our previous studies, we have demonstrated that miR-369-3p regulates inflammatory responses, modulating different aspects of the inflammatory process. The aim of this study was to demonstrate an additional anti-inflammatory effect of miR-369-3p targeting PDE4B, one of the widely expressed isoforms in immune cells. We found that miR-369-3p was able to reduce the expression of PDE4B, elevating the intracellular levels of cAMP. This accumulation increased the expression of PKA and pCREB, mitigating the release of pro-inflammatory cytokines and promoting the release of anti-inflammatory cytokines. To prove that PDE4B is a good therapeutic target in IBD, we also demonstrate that the expression of PDE4B was increased in UC patients compared to healthy controls, affecting the immune infiltrate. PDE4B is considered an important player in inflammatory progression; hence, our results show the ability of miR-369-3p to ameliorate inflammation by targeting PDE4B, supporting its future application as a new therapeutic approach in IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, 70013 Castellana Grotte, Italy.
ORCID-Profile: Viviana Scalavino, Emanuele Piccinno, Raffaele Armentano, Gianluigi Giannelli, Grazia Serino
Förderung
- Ministero della Salute
- Italian Ministry of Health
Zitieren
APA
Scalavino, V., Piccinno, E., Labarile, N., Armentano, R., Giannelli, G., & Serino, G. (2024). Anti-Inflammatory Effects of miR-369-3p via PDE4B in Intestinal Inflammatory Response. International Journal of Molecular Sciences, 25(15), 8463. https://doi.org/10.3390/ijms25158463
Vancouver
Scalavino V, Piccinno E, Labarile N, Armentano R, Giannelli G, Serino G. Anti-Inflammatory Effects of miR-369-3p via PDE4B in Intestinal Inflammatory Response. International Journal of Molecular Sciences. 2024;25(15):8463. doi:10.3390/ijms25158463
BibTeX
@article{Scalavino2024,
author = {Scalavino, Viviana and Piccinno, Emanuele and Labarile, Nicoletta and Armentano, Raffaele and Giannelli, Gianluigi and Serino, Grazia},
title = {Anti-Inflammatory Effects of miR-369-3p via PDE4B in Intestinal Inflammatory Response},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {15},
pages = {8463},
doi = {10.3390/ijms25158463}
}
EUVIMED